Internal Medicine, Clinical Cardiatric Electrophysiology · Lakeland, FL
NPI
1063484822
Since 2006
Specialty
Internal Medicine, Clinical Cardiatric Electrophysiology
Code 207RC0001X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1600 Lakeland Hills Blvd
Lakeland, FL, 33805
Phone (863) 680-7490
Groups this clinician bills Medicare through
Medicare paid, 2024
$487K
8,502 services
Medicare patients, 2024
1,286
Average age 79
Drug cost, 2024
$1.6M
5,808 prescriptions
Company payments, 2025
$323
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Neal G Kavesh was code 93296 (external electrocardiographic monitoring), 1,237 times for 524 patients. In total Neal G Kavesh billed 8,502 services in 90 codes, and Medicare paid $487K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93296 External Electrocardiographic Monitoring | Office | 1,237 | 524 | $13.91 | $17K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,030 | 753 | $12.07 | $12K |
| 99214 Office E&M - Established | Office | 900 | 692 | $89.73 | $81K |
| 93294 External Electrocardiographic Monitoring | Office | 655 | 295 | $19.93 | $13K |
| 93793 Care Management/Coordination | Office | 604 | 33 | $7.80 | $4,714 |
| 93295 External Electrocardiographic Monitoring | Office | 589 | 235 | $24.65 | $15K |
| 93010 Electrocardiogram | Facility | 475 | 189 | $6.26 | $2,971 |
| 99233 Hospital E&M - Subsequent | Facility | 449 | 170 | $91.70 | $41K |
| 93000 Electrocardiogram | Office | 211 | 168 | $10.85 | $2,289 |
| 99152 Anesthesia | Facility | 197 | 169 | $9.62 | $1,894 |
| 99223 Hospital E&M - Initial | Facility | 177 | 164 | $132.13 | $23K |
| 93306 Echocardiography (TTE/TEE) | Office | 176 | 173 | $134.87 | $24K |
| 93280 External Electrocardiographic Monitoring | Office | 133 | 125 | $51.65 | $6,870 |
| 99204 Office E&M - New | Office | 103 | 103 | $123.00 | $13K |
| 93306 Echocardiography (TTE/TEE) | Facility | 101 | 99 | $50.92 | $5,143 |
By year: 2022 $511K for 7,645 services; 2023 $479K for 7,465 services; 2024 $487K for 8,502 services.
Medicare prescription drug claims, 2024
In 2024, the drug Neal G Kavesh prescribed most often to Medicare patients was Eliquis (Apixaban), with 884 prescriptions and refills. In total Neal G Kavesh wrote 5,808 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 884 | 1,626 | 185 | $928K |
| Sotalol Sotalol Hcl | 643 | 1,689 | 183 | $15K |
| Dofetilide Generic | 468 | 1,025 | 114 | $107K |
| Furosemide Generic | 338 | 919 | 110 | $1,636 |
| Metoprolol Succinate Generic | 318 | 868 | 116 | $4,905 |
| Carvedilol Generic | 264 | 768 | 98 | $2,421 |
| Amiodarone Hcl Generic | 261 | 678 | 90 | $4,284 |
| Xarelto Rivaroxaban | 206 | 418 | 48 | $227K |
| Flecainide Acetate Generic | 204 | 551 | 62 | $8,175 |
| Spironolactone Generic | 202 | 579 | 65 | $1,574 |
| Entresto Sacubitril/Valsartan | 181 | 278 | 35 | $176K |
| Losartan Potassium Generic | 173 | 508 | 56 | $2,099 |
| Amlodipine Besylate Generic | 142 | 364 | 40 | $1,005 |
| Atorvastatin Calcium Generic | 140 | 422 | 46 | $1,626 |
| Lisinopril Generic | 128 | 378 | 41 | $1,139 |
Brand drugs: 1,495 claims; generic drugs: 4,313 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Neal G Kavesh $323 ($323 in general payments such as food, travel and fees) from 5 companies. The largest payer was Boston Scientific Corporation with $241.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.